
    
      This study is designed to determine the safety, tolerance and efficacy of POZ used as
      prophylaxis if IFI in high-risk subjects with prolonged profound neutropenia. The primary
      objective is to assess the efficacy of SCH 56592 vs fluconazole and itraconazole in
      preventing proven or probable IFI during neutropenic episodes.
    
  